Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025
Sensus Healthcare (Nasdaq: SRTS), a medical device company focused on non-invasive and minimally-invasive treatments for skin conditions, has scheduled its 2024 fourth quarter and full year financial results announcement for Wednesday, February 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss results and provide a business update.
Participants can pre-register for the call through a provided link for a unique dial-in number, or join by dialing 844-481-2811 (U.S./Canada) or 412-317-0676 (International). The call will be webcast live and available for replay until March 5th, with replay numbers provided for U.S., Canada, and International callers.
Sensus Healthcare (Nasdaq: SRTS), un'azienda di dispositivi medici focalizzata su trattamenti non invasivi e minimamente invasivi per le condizioni cutanee, ha programmato l'annuncio dei risultati finanziari per il quarto trimestre e l'intero anno 2024 per mercoledì 5 febbraio 2025. L'azienda ospiterà una teleconferenza alle 16:30 ora orientale per discutere i risultati e fornire un aggiornamento aziendale.
I partecipanti possono preregistrarsi per la chiamata tramite un link fornito per un numero di accesso unico, oppure unirsi componendo 844-481-2811 (U.S./Canada) o 412-317-0676 (Internazionale). La chiamata sarà trasmessa in diretta e disponibile per la riproduzione fino al 5 marzo, con numeri di riproduzione forniti per i chiamanti statunitensi, canadesi e internazionali.
Sensus Healthcare (Nasdaq: SRTS), una empresa de dispositivos médicos centrada en tratamientos no invasivos y mínimamente invasivos para condiciones de la piel, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para miércoles, 5 de febrero de 2025. La empresa realizará una conferencia telefónica a las 4:30 p.m. hora del Este para discutir los resultados y proporcionar una actualización comercial.
Los participantes pueden preinscribirse para la llamada a través de un enlace proporcionado para un número de acceso único o unirse marcando 844-481-2811 (EE. UU./Canadá) o 412-317-0676 (Internacional). La llamada se transmitirá en vivo y estará disponible para su repetición hasta el 5 de marzo, con números de repetición proporcionados para las llamadas de EE. UU., Canadá e Internacional.
Sensus Healthcare (Nasdaq: SRTS)는 피부 상태에 대한 비침습적 및 최소 침습적 치료에 집중하는 의료 기기 회사로, 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 5일 수요일로 예정하고 있습니다. 회사는 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 주최할 예정입니다.
참가자는 제공된 링크를 통해 고유한 다이얼 인 번호로 사전 등록하거나 844-481-2811 (미국/캐나다) 또는 412-317-0676 (국제)으로 직접 참여할 수 있습니다. 전화는 실시간으로 웹캐스트되며 3월 5일까지 재생이 가능하며, 미국, 캐나다 및 국제 전화에 대한 재생 번호가 제공됩니다.
Sensus Healthcare (Nasdaq: SRTS), une entreprise de dispositifs médicaux axée sur des traitements non invasifs et peu invasifs pour les affections cutanées, a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour mercredi 5 février 2025. L'entreprise organisera une conférence téléphonique à 16h30, heure de l'Est, pour discuter des résultats et fournir une mise à jour sur les activités.
Les participants peuvent s'inscrire à l'avance pour l'appel via un lien fourni pour obtenir un numéro d'appel unique, ou rejoindre en composant le 844-481-2811 (États-Unis/Canada) ou le 412-317-0676 (International). L'appel sera diffusé en direct et disponible en rediffusion jusqu'au 5 mars, avec des numéros de rediffusion fournis pour les appelants des États-Unis, du Canada et international.
Sensus Healthcare (Nasdaq: SRTS), ein Unternehmen für medizinische Geräte, das sich auf nicht-invasive und minimal-invasive Behandlungen von Hauterkrankungen konzentriert, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Mittwoch, den 5. Februar 2025 angesetzt. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und ein Update zum Geschäft zu geben.
Teilnehmer können sich über einen bereitgestellten Link für eine einzigartige Einwahlnummer vorregistrieren oder sich unter 844-481-2811 (USA/Kanada) oder 412-317-0676 (international) einwählen. Die Konferenz wird live im Internet übertragen und ist bis zum 5. März für eine Wiederholung verfügbar, mit angegebener Rufnummer für Anrufer aus den USA, Kanada und international.
- None.
- None.
Participants are encouraged to pre-register for the conference call using this link to receive a unique dial-in number to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those unable to pre-register can access the conference call by dialing 844-481-2811 (
The call will be webcast live and can be accessed at this link, which is also in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until March 5th by dialing 877-344-7529 (
About Sensus Healthcare
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122504110/en/
Alliance Advisors IR
Tirth T. Patel
tpatel@allianceadvisors.com
212-201-6614
Source: Sensus Healthcare
FAQ
When will Sensus Healthcare (SRTS) release Q4 and full year 2024 earnings?
What time is the SRTS Q4 2024 earnings conference call?
How can investors access the SRTS Q4 2024 earnings call?
How long will the SRTS Q4 2024 earnings call replay be available?
